Introduction about CTD, NeeS & eCTD.pdf
•
0 likes•327 views
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like depression and anxiety.
Report
Share
Report
Share
Download to read offline
Recommended
International Medical Device Regulators Forum
The document summarizes the International Medical Device Regulators Forum (IMDRF), which was established in 2011 to accelerate international harmonization of medical device regulations. It provides background on IMDRF's establishment and membership, which includes regulators from 11 countries and regions. The document also discusses IMDRF's relationship to the prior Global Harmonization Task Force (GHTF) and describes IMDRF's management structure, meetings, and current working groups on issues like adverse event terminology and medical device cybersecurity.
Premarket notification
The document outlines the steps for preparing a premarket notification submission or 510(k) for a medical device. The first step is to identify the product code, regulation number and review panel by searching the FDA classification database. The second step is identifying a predicate device that is already legally marketed and determining substantial equivalence by comparing the intended use, materials, and other characteristics. The third step is preparing the submission file which should refer to any special control guidance documents and take the format of an abbreviated or traditional 510(k) depending on guidance availability.
REGULATORY CONSIDERATIONS IN JAPAN.pptx
The document summarizes regulatory considerations for pharmaceuticals in Japan, including manufacturing, packaging, labeling, and post-marketing surveillance. For manufacturing, drugs must be approved by the Ministry of Health, Labor and Welfare and manufacturers must be licensed and follow good manufacturing practices. Packaging and labeling must contain specified information and any changes require relabeling. Post-marketing surveillance involves adverse event reporting, drug reexaminations every few years to reconfirm safety and efficacy, and reevaluations based on current medical knowledge.
Dossier format and filing.pptx
The document filing for a pharmaceutical product is done in the form of dossier. The slides explain the format and content to be included in all the formats of dossiers.
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
The document discusses regulatory requirements for drug registration in Asian countries. It provides an overview of the ASEAN Common Technical Dossier (ACTD) format for drug applications across ASEAN countries. It then summarizes requirements for registration in China, South Korea, and with the ASEAN region. For China, it outlines the drug classification system and two-step approval process. For South Korea, it describes the drug classification and approval process including investigational new drug applications. It also provides background on the goals and formation of the ASEAN economic alliance between Southeast Asian countries.
Electronic submission PPT
The document discusses the regulatory process for electronic submissions to regulatory authorities. It is divided into four steps - planning, document preparation, publishing the dossier, and submission. It provides guidance on tools for planning like checklists, templates, and timelines. It also discusses the eCTD format, FDA Electronic Submissions Gateway for submitting to FDA, and validation checks. Non-eCTD electronic submissions and ACTD format are also summarized.
ISO 14155.pdf
A guideline on medical devices designed internationally for harmonization.
As the site access is unavailable have managed the data for easy access of the details for the Regulatory affairs aspirants of Masters of Pharmacy
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
In Japan, the pharmaceutical industry operates under strict regulatory oversight by the Pharmaceutical and Medical Devices Agency (PMDA). Established in 2004, PMDA functions within the Ministry of Health, Labour and Welfare (MHLW). The regulatory landscape is primarily governed by the Pharmaceuticals and Medical Devices Law (PMDL), which outlines the requirements for drug approval, clinical trials, manufacturing, and marketing authorization. Companies seeking to introduce pharmaceutical products into the Japanese market must navigate various types of registration applications, including New Drug Applications (NDA) for new products, Marketing Authorization Holder (MAH) Applications for market entry, and Generic Drug Applications for approval of generic versions of existing drugs. Understanding these regulations and application processes is crucial for companies operating in Japan's pharmaceutical sector.
Recommended
International Medical Device Regulators Forum
The document summarizes the International Medical Device Regulators Forum (IMDRF), which was established in 2011 to accelerate international harmonization of medical device regulations. It provides background on IMDRF's establishment and membership, which includes regulators from 11 countries and regions. The document also discusses IMDRF's relationship to the prior Global Harmonization Task Force (GHTF) and describes IMDRF's management structure, meetings, and current working groups on issues like adverse event terminology and medical device cybersecurity.
Premarket notification
The document outlines the steps for preparing a premarket notification submission or 510(k) for a medical device. The first step is to identify the product code, regulation number and review panel by searching the FDA classification database. The second step is identifying a predicate device that is already legally marketed and determining substantial equivalence by comparing the intended use, materials, and other characteristics. The third step is preparing the submission file which should refer to any special control guidance documents and take the format of an abbreviated or traditional 510(k) depending on guidance availability.
REGULATORY CONSIDERATIONS IN JAPAN.pptx
The document summarizes regulatory considerations for pharmaceuticals in Japan, including manufacturing, packaging, labeling, and post-marketing surveillance. For manufacturing, drugs must be approved by the Ministry of Health, Labor and Welfare and manufacturers must be licensed and follow good manufacturing practices. Packaging and labeling must contain specified information and any changes require relabeling. Post-marketing surveillance involves adverse event reporting, drug reexaminations every few years to reconfirm safety and efficacy, and reevaluations based on current medical knowledge.
Dossier format and filing.pptx
The document filing for a pharmaceutical product is done in the form of dossier. The slides explain the format and content to be included in all the formats of dossiers.
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
The document discusses regulatory requirements for drug registration in Asian countries. It provides an overview of the ASEAN Common Technical Dossier (ACTD) format for drug applications across ASEAN countries. It then summarizes requirements for registration in China, South Korea, and with the ASEAN region. For China, it outlines the drug classification system and two-step approval process. For South Korea, it describes the drug classification and approval process including investigational new drug applications. It also provides background on the goals and formation of the ASEAN economic alliance between Southeast Asian countries.
Electronic submission PPT
The document discusses the regulatory process for electronic submissions to regulatory authorities. It is divided into four steps - planning, document preparation, publishing the dossier, and submission. It provides guidance on tools for planning like checklists, templates, and timelines. It also discusses the eCTD format, FDA Electronic Submissions Gateway for submitting to FDA, and validation checks. Non-eCTD electronic submissions and ACTD format are also summarized.
ISO 14155.pdf
A guideline on medical devices designed internationally for harmonization.
As the site access is unavailable have managed the data for easy access of the details for the Regulatory affairs aspirants of Masters of Pharmacy
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
In Japan, the pharmaceutical industry operates under strict regulatory oversight by the Pharmaceutical and Medical Devices Agency (PMDA). Established in 2004, PMDA functions within the Ministry of Health, Labour and Welfare (MHLW). The regulatory landscape is primarily governed by the Pharmaceuticals and Medical Devices Law (PMDL), which outlines the requirements for drug approval, clinical trials, manufacturing, and marketing authorization. Companies seeking to introduce pharmaceutical products into the Japanese market must navigate various types of registration applications, including New Drug Applications (NDA) for new products, Marketing Authorization Holder (MAH) Applications for market entry, and Generic Drug Applications for approval of generic versions of existing drugs. Understanding these regulations and application processes is crucial for companies operating in Japan's pharmaceutical sector.
How to implement a successful regulatory due diligence.pdf
How to implement a successful regulatory due diligence, in order to grant the DP MA license on a short time frame?, and What are the Formatting requirements for eCTD Publishing?
Registration procedure of drugs in european union
This document outlines various procedures for registering medicinal products in the European Union. It describes the centralized procedure administered by the European Medicines Agency and national procedures administered by individual member states. It also covers the mutual recognition and decentralized procedures which allow registration in multiple member states based on one member state's assessment. There are also simplified registration procedures for certain herbal medicinal products.
How to gather the CMC documents.pdf
How to gather the CMC documents?, and how to develop your knowledge as to manage the compilation of a harmonized CTD ?
regulatory aspects of medical devices in USA
introduction, classification, regulatory approval process for medical devices (510k) premarket notification, pre market approval (PMA), investigational device exemption (IDE) and invitro diagnostics, quality system requirements 21 CFR PART 820, labeling requirements 21 CFR part 801, UDI
Fda med watch
MedWatch is the FDA's program for monitoring the safety of medical products. It allows voluntary reporting of adverse events by the public and healthcare professionals. Reports are collected in a database and monitored by FDA professionals. The FDA uses these reports to identify safety issues, communicate new safety information to the public and healthcare providers, and take regulatory actions like requiring label changes or product recalls when needed. The goal is to help protect public health by ensuring the safety of drugs, medical devices and other medical products.
Doc in pharma
The document provides information on documentation practices in the pharmaceutical industry. It discusses why documentation is important, defining documentation as written evidence of activities. It states that regulatory bodies prioritize reviewing documents to verify activities. Good documentation practices, including systematic preparation and review of documents, are required to prevent errors and ensure compliance. Documentation provides records, traceability, and audit trails for investigation and review.
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
The document discusses guidelines for Active Substance Master Files (ASMF) and European Drug Master Files (EDMF) in the European Union. Some key points:
- An ASMF/EDMF contains quality and quality control information for an active pharmaceutical ingredient. It has two parts - an applicant part given to marketing authorization applicants, and a restricted part for regulatory authorities.
- The ASMF procedure can be used for new active substances, existing substances not in pharmacopeias, and pharmacopeial substances. It cannot be used for biological substances.
- Marketing authorization applicants must include specified information from the ASMF in their application dossier and have access to the current active substance manufacturer. ASMF
Combination product
COMBINATION PRODUCT THAT CONSIST COMBINATION OF MEDICAL DEVICE WITH DRUG, DRUG WITH BOILOGICAL PRODUCT, DRUG WITH DRUG ETC.
eCTD Submissions
Disclaimer:
I have created this document with inputs from various sources. Some are taken right from slideshare. I just try to make this topic little compact and lucid, so that everybody can understand it easily
I am very much thankful to the original authors also, don't think I am just doing plagarism.
Process Validation & Verification (V&V) for Medical Devices
This document is a presentation on process validation and verification. It discusses six focus areas for ensuring a consistent and controlled process from prototype to finished product: getting CEO commitment, establishing an interdisciplinary team, starting early in product development, knowing suppliers and subcontractors, mapping processes, and understanding sources of variability. It provides examples and advice for each area, such as creating a multidisciplinary team to understand all factors that could affect variability, developing a quality agreement with suppliers, and process mapping to get consensus on how processes are actually performed. The overarching message is that effective process validation requires a holistic and systematic approach across the entire organization.
FDA Unique Device Identification (UDI) Overview
Presentation on UDI for Grace College Orthopaedic Regulatory and Clinical Affairs graduate program (RCA5700)
Regulation of Medical Devices in US
The document discusses the regulation of medical devices in the United States. It begins by defining what constitutes a medical device according to the Code of Federal Regulations. It then outlines the key regulatory bodies that oversee medical devices, including the Center for Devices and Radiological Health and the Office of Combination Products. The document provides an overview of the classification system for medical devices and the different regulatory pathways for approval, including 510(k) premarket notification, investigational device exemptions, premarket approval, and humanitarian device exemption. It also summarizes the key requirements and processes for each approval pathway.
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
1) The Global Medical Device Nomenclature (GMDN) is an internationally agreed system that provides a single common language of generic terms to uniquely identify medical devices. It aims to be adopted by medical device regulators, manufacturers and healthcare systems worldwide.
2) GMDN terms consist of a name, definition and code. Terms are searched on the GMDN agency website and used for data exchange between organizations. A unique device identifier (UDI) also uses GMDN codes.
3) GMDN was established in 1991 to allow efficient information exchange between stakeholders. It is important for regulatory approval and identification of product failures or inventory management.
GHTF
This document summarizes the objectives and classification system of the Global Harmonization Task Force (GHTF) for in vitro diagnostic (IVD) medical devices. The GHTF was founded in 1993 to harmonize medical device regulations globally. It aims to facilitate trade while preserving public health. IVD medical devices are classified into 4 risk-based classes (A to D) based on 16 general rules related to device invasiveness, energy use, and disease detection. Class A devices pose the lowest risk while Class D the highest. The classification system aims to ensure regulatory oversight is proportionate to device risk.
21 CFR 820 and 801 pptx.pdf
21 CFR Part 820 Quality system requirement and 21 CFR Part 801 Labeling requirement for Medical Device
Regulatory requirements for orphan drugs delivery
Regulatory requirements for orphan drugs delivery, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belgavi/Belgaum, Karnataka, India.
eCTD Submissions
The document discusses the requirements and specifications for submitting applications to the FDA using the electronic common technical document (eCTD) format. It states that eCTD is the standard format for submissions to the Center for Biologics Evaluation and Research and the Center for Drug Evaluation and Research. The document outlines the five modules that make up an eCTD submission and provides details on submission types, required formats, pre-submission requirements like obtaining an application number, and how to transmit submissions through the Electronic Submissions Gateway.
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
the presentation give idea about what is medical devices?
definition's given by cdsco and usfda
what is clinical investigation in evaluation in medical devices?
Cfr code of federal regulations-1 (1)
The document summarizes the Code of Federal Regulations Title 21 Part 822, which provides procedures and requirements for post-market surveillance of medical devices. It outlines the subparts which address general provisions, notification, post-market surveillance plans, FDA review and action, responsibilities of manufacturers, waivers and exemptions, and records and reports. The purpose is to implement post-market surveillance authority to maximize collection of useful safety data on medical devices after market release. Manufacturers must submit surveillance plans for FDA approval and are responsible for conducting approved plans to monitor devices and report data and issues.
US FDA post approval changes
The document discusses post-approval changes that can be made to approved NDAs and ANDAs. It describes four reporting categories for post-approval changes based on their potential impact: major changes requiring prior approval, moderate changes reported via a CBE-30 or CBE-0 supplement, minor changes reported annually. Examples are provided for different types of changes that fall under each reporting category. The levels of reporting ensure that manufacturers can make certain changes while providing appropriate notification to the FDA depending on the level of change.
Product type- Drug development - Departments of facility- Registration pathwa...
In this video you will know the detailed information about:
🔸Departments of the manufacturing sites.
🔸Steps of drug product development.
🔸Regulatory Affairs department.
🔸Registration pathway.
🔸Product Type (Innovator "RLD" / Generic / Hybrid).
🔸All medicines must grant a Marketing Authorization (MA) in order to be placed on the market legally in the country.
🔸The ultimate purpose of marketing authorization is to ensure that safe, effective & high-quality medicines, as to protect public health.
https://youtu.be/edUEFt681iM
#asmaa_khalil_ctd
Different Export Prices of Medicinal Drugs.pdf
The document discusses different price levels for drugs from factory to public. The EX-Factory price is the cost from the seller's factory. The wholesaler price is between the factory and pharmacies. The public or retail price is what pharmacies charge the public. It also defines CIF, FOB, and CFR pricing terms for exports, with CIF including cost, freight, and insurance, FOB including just cost, and CFR including cost and freight but not insurance. Export prices generally use CIF or FOB, rarely CFR.
More Related Content
What's hot
How to implement a successful regulatory due diligence.pdf
How to implement a successful regulatory due diligence, in order to grant the DP MA license on a short time frame?, and What are the Formatting requirements for eCTD Publishing?
Registration procedure of drugs in european union
This document outlines various procedures for registering medicinal products in the European Union. It describes the centralized procedure administered by the European Medicines Agency and national procedures administered by individual member states. It also covers the mutual recognition and decentralized procedures which allow registration in multiple member states based on one member state's assessment. There are also simplified registration procedures for certain herbal medicinal products.
How to gather the CMC documents.pdf
How to gather the CMC documents?, and how to develop your knowledge as to manage the compilation of a harmonized CTD ?
regulatory aspects of medical devices in USA
introduction, classification, regulatory approval process for medical devices (510k) premarket notification, pre market approval (PMA), investigational device exemption (IDE) and invitro diagnostics, quality system requirements 21 CFR PART 820, labeling requirements 21 CFR part 801, UDI
Fda med watch
MedWatch is the FDA's program for monitoring the safety of medical products. It allows voluntary reporting of adverse events by the public and healthcare professionals. Reports are collected in a database and monitored by FDA professionals. The FDA uses these reports to identify safety issues, communicate new safety information to the public and healthcare providers, and take regulatory actions like requiring label changes or product recalls when needed. The goal is to help protect public health by ensuring the safety of drugs, medical devices and other medical products.
Doc in pharma
The document provides information on documentation practices in the pharmaceutical industry. It discusses why documentation is important, defining documentation as written evidence of activities. It states that regulatory bodies prioritize reviewing documents to verify activities. Good documentation practices, including systematic preparation and review of documents, are required to prevent errors and ensure compliance. Documentation provides records, traceability, and audit trails for investigation and review.
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
The document discusses guidelines for Active Substance Master Files (ASMF) and European Drug Master Files (EDMF) in the European Union. Some key points:
- An ASMF/EDMF contains quality and quality control information for an active pharmaceutical ingredient. It has two parts - an applicant part given to marketing authorization applicants, and a restricted part for regulatory authorities.
- The ASMF procedure can be used for new active substances, existing substances not in pharmacopeias, and pharmacopeial substances. It cannot be used for biological substances.
- Marketing authorization applicants must include specified information from the ASMF in their application dossier and have access to the current active substance manufacturer. ASMF
Combination product
COMBINATION PRODUCT THAT CONSIST COMBINATION OF MEDICAL DEVICE WITH DRUG, DRUG WITH BOILOGICAL PRODUCT, DRUG WITH DRUG ETC.
eCTD Submissions
Disclaimer:
I have created this document with inputs from various sources. Some are taken right from slideshare. I just try to make this topic little compact and lucid, so that everybody can understand it easily
I am very much thankful to the original authors also, don't think I am just doing plagarism.
Process Validation & Verification (V&V) for Medical Devices
This document is a presentation on process validation and verification. It discusses six focus areas for ensuring a consistent and controlled process from prototype to finished product: getting CEO commitment, establishing an interdisciplinary team, starting early in product development, knowing suppliers and subcontractors, mapping processes, and understanding sources of variability. It provides examples and advice for each area, such as creating a multidisciplinary team to understand all factors that could affect variability, developing a quality agreement with suppliers, and process mapping to get consensus on how processes are actually performed. The overarching message is that effective process validation requires a holistic and systematic approach across the entire organization.
FDA Unique Device Identification (UDI) Overview
Presentation on UDI for Grace College Orthopaedic Regulatory and Clinical Affairs graduate program (RCA5700)
Regulation of Medical Devices in US
The document discusses the regulation of medical devices in the United States. It begins by defining what constitutes a medical device according to the Code of Federal Regulations. It then outlines the key regulatory bodies that oversee medical devices, including the Center for Devices and Radiological Health and the Office of Combination Products. The document provides an overview of the classification system for medical devices and the different regulatory pathways for approval, including 510(k) premarket notification, investigational device exemptions, premarket approval, and humanitarian device exemption. It also summarizes the key requirements and processes for each approval pathway.
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
1) The Global Medical Device Nomenclature (GMDN) is an internationally agreed system that provides a single common language of generic terms to uniquely identify medical devices. It aims to be adopted by medical device regulators, manufacturers and healthcare systems worldwide.
2) GMDN terms consist of a name, definition and code. Terms are searched on the GMDN agency website and used for data exchange between organizations. A unique device identifier (UDI) also uses GMDN codes.
3) GMDN was established in 1991 to allow efficient information exchange between stakeholders. It is important for regulatory approval and identification of product failures or inventory management.
GHTF
This document summarizes the objectives and classification system of the Global Harmonization Task Force (GHTF) for in vitro diagnostic (IVD) medical devices. The GHTF was founded in 1993 to harmonize medical device regulations globally. It aims to facilitate trade while preserving public health. IVD medical devices are classified into 4 risk-based classes (A to D) based on 16 general rules related to device invasiveness, energy use, and disease detection. Class A devices pose the lowest risk while Class D the highest. The classification system aims to ensure regulatory oversight is proportionate to device risk.
21 CFR 820 and 801 pptx.pdf
21 CFR Part 820 Quality system requirement and 21 CFR Part 801 Labeling requirement for Medical Device
Regulatory requirements for orphan drugs delivery
Regulatory requirements for orphan drugs delivery, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belgavi/Belgaum, Karnataka, India.
eCTD Submissions
The document discusses the requirements and specifications for submitting applications to the FDA using the electronic common technical document (eCTD) format. It states that eCTD is the standard format for submissions to the Center for Biologics Evaluation and Research and the Center for Drug Evaluation and Research. The document outlines the five modules that make up an eCTD submission and provides details on submission types, required formats, pre-submission requirements like obtaining an application number, and how to transmit submissions through the Electronic Submissions Gateway.
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
the presentation give idea about what is medical devices?
definition's given by cdsco and usfda
what is clinical investigation in evaluation in medical devices?
Cfr code of federal regulations-1 (1)
The document summarizes the Code of Federal Regulations Title 21 Part 822, which provides procedures and requirements for post-market surveillance of medical devices. It outlines the subparts which address general provisions, notification, post-market surveillance plans, FDA review and action, responsibilities of manufacturers, waivers and exemptions, and records and reports. The purpose is to implement post-market surveillance authority to maximize collection of useful safety data on medical devices after market release. Manufacturers must submit surveillance plans for FDA approval and are responsible for conducting approved plans to monitor devices and report data and issues.
US FDA post approval changes
The document discusses post-approval changes that can be made to approved NDAs and ANDAs. It describes four reporting categories for post-approval changes based on their potential impact: major changes requiring prior approval, moderate changes reported via a CBE-30 or CBE-0 supplement, minor changes reported annually. Examples are provided for different types of changes that fall under each reporting category. The levels of reporting ensure that manufacturers can make certain changes while providing appropriate notification to the FDA depending on the level of change.
What's hot (20)
How to implement a successful regulatory due diligence.pdf
How to implement a successful regulatory due diligence.pdf
Â
Process Validation & Verification (V&V) for Medical Devices
Process Validation & Verification (V&V) for Medical Devices
Â
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
Â
More from Asmaa Khalil
Product type- Drug development - Departments of facility- Registration pathwa...
In this video you will know the detailed information about:
🔸Departments of the manufacturing sites.
🔸Steps of drug product development.
🔸Regulatory Affairs department.
🔸Registration pathway.
🔸Product Type (Innovator "RLD" / Generic / Hybrid).
🔸All medicines must grant a Marketing Authorization (MA) in order to be placed on the market legally in the country.
🔸The ultimate purpose of marketing authorization is to ensure that safe, effective & high-quality medicines, as to protect public health.
https://youtu.be/edUEFt681iM
#asmaa_khalil_ctd
Different Export Prices of Medicinal Drugs.pdf
The document discusses different price levels for drugs from factory to public. The EX-Factory price is the cost from the seller's factory. The wholesaler price is between the factory and pharmacies. The public or retail price is what pharmacies charge the public. It also defines CIF, FOB, and CFR pricing terms for exports, with CIF including cost, freight, and insurance, FOB including just cost, and CFR including cost and freight but not insurance. Export prices generally use CIF or FOB, rarely CFR.
Global medicine regulatory authorities websites.pdf
This document lists regulatory authorities' websites for medicines in various countries and regions. It includes 38 websites for countries in Africa and the Eastern Mediterranean, 21 websites for countries in Europe and European authorities, 19 websites for countries in the Americas, 36 websites for countries in Asia, and 11 websites for countries in Russia and the CIS region. The websites listed are mainly for countries' ministries of health and medicines regulatory authorities.
CMC EU GCC.pdf
This document provides an overview of Gulf and European registration pathways for pharmaceutical products. It compares the registration processes and requirements between the Gulf Cooperation Council (GCC) countries and the European Union (EU). Specifically, it outlines the national and centralized registration options in GCC countries and EU, compares Module 1 requirements and chemistry, manufacturing and controls (CMC) data requirements between GCC and EU dossiers. It also provides timelines and performance targets for the different registration procedures in Saudi Food and Drug Authority (SFDA) and the EU.
Improve CV develop career.pdf
The document provides tips for improving CVs and developing careers in the pharmaceutical field. It recommends including personal details, education, computer skills, training courses, and checking for spelling errors on CVs. It also lists various career opportunities for pharmacists and free online trainings from global organizations covering medicine, pharmaceutical industry topics, and good manufacturing practices. Contact details are provided for networking and sharing beneficial resources.
Global MOH websites.pdf
This document lists links to various ministries of health and medicine regulatory authority websites around the world, organized by region. It includes over 150 links to websites for countries in Africa, the Eastern Mediterranean, Asia, Europe, and the Americas. The websites provided are for organizations that regulate medicines and pharmaceutical products in their respective countries.
nce-230101125835-9a686300.pdf
The document lists 17 new molecular entities approved by the FDA in 2022, including drugs to treat insomnia, eczema, hemolytic anemia, myelofibrosis, seizures, prostate cancer, vulvovaginal candidiasis, hypertrophic cardiomyopathy, Helicobacter pylori infection, type 2 diabetes mellitus, plaque psoriasis, polyneuropathy of hereditary transthyretin-mediated amyloidosis, hepatorenal syndrome, elevated intraocular pressure, amyotrophic lateral sclerosis, bile duct cancer, acute myeloid leukemia, non-small cell lung cancer, HIV-1 infection, and as a hyperpolarized contrast agent. Each drug is listed with its active ingredient
Authentication.pdf
To formally attest to a signature on a document, a notary public will sign and stamp the document with their seal after verifying the identity of the signer. For countries that have signed the Hague Convention, only an apostille is needed, which is a certificate attached to the document by the Ministry of Foreign Affairs to authenticate the notary's seal. If the country is not part of the Hague Convention, the document must go through a process of legalization where each country's authorities further authenticate the document so it will be recognized as valid.
CPV.pdf
The document discusses various aspects of process validation including:
- The three stages of process validation: process design, process qualification, and continued process verification.
- Key definitions related to process validation including qualification, validation, and continued process verification.
- The importance of process validation in ensuring consistent quality and reducing risk.
- Key documents required for stage 1 process design including development reports and control strategy documents.
Regulatory due diligence.pdf
The document discusses common conflicts and pains that can lead to delays in the drug registration process from a commercial point of view. It identifies several key challenges, including lacking a project plan, regulatory intelligence, and issues with CMC data for both drug substances and drug products. Specific problems are outlined, such as invalid certificates, missing documentation, and inconsistencies between dossier sections. Recommendations are provided on how to address these challenges to minimize timelines and cut costs in the registration process.
Registration in Gulf & EU.pdf
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
EU RA Pathways.pdf
This document summarizes the different types of marketing authorizations (MAs) in the European Union. There are national MAs granted by individual countries, as well as mutual recognition procedures (MRP), decentralized procedures (DCP), and centralized procedures (CP) which allow approval in multiple EU states. The MRP and DCP rely on one state conducting an initial assessment, while the CP provides a single approval valid across all EU states. Applications must demonstrate a positive benefit-risk assessment based on quality, safety, and efficacy considerations.
Career opportunities
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacies, hospitals, and the pharmaceutical industry. It also mentions roles in government agencies, academia, and research. The document then provides tips for career development like obtaining additional education and skills through online courses from organizations like USP, WHO, and Uppsala Monitoring Centre. It emphasizes the importance of ongoing learning and lists social media and networking platforms like LinkedIn for connecting with others in the field.
Career opportunities
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacy, hospitals, and industry. Industry roles include departments like quality assurance, production, and regulatory affairs. Other career paths include government agencies and academic/research. The document then provides suggestions for education and skills development like online courses from USP, WHO, and Uppsala Monitoring Centre on topics like GMP, pharmacovigilance, and COVID-19. It also recommends connecting on LinkedIn and Facebook for virtual meetings on career planning, entrepreneurship, and digital skills.
Registration in Gulf & EU
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
More from Asmaa Khalil (15)
Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...
Â
Global medicine regulatory authorities websites.pdf
Global medicine regulatory authorities websites.pdf
Â
Recently uploaded
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Dehradun #â„‚all #gIRLS Oyo Hotel 8107221448 #â„‚all #gIRL in Dehradun
Dehradun #â„‚all #gIRLS Oyo Hotel 8107221448 #â„‚all #gIRL in Dehradun
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Top 10 Best Ayurvedic Kidney Stone Syrups in India
we have mentioned the best 10 ayurvedic Kidney Stone Syrups. You can check all these products and choose the best one for yourself.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recently uploaded (20)
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Â
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Â
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Â
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Â
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Â
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Â
Dehradun #â„‚all #gIRLS Oyo Hotel 8107221448 #â„‚all #gIRL in Dehradun
Dehradun #â„‚all #gIRLS Oyo Hotel 8107221448 #â„‚all #gIRL in Dehradun
Â
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Â
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Â
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Â
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Â
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Â